Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
for APOL1-Mediated Kidney Disease
Sites in New Orleans, Baton Rouge +76 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 65
Code: NCT06824987·Phase 2·Recruiting·Listed Feb 2025